$197 Million is the total value of Cabot-Wellington, LLC's 17 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HON | Honeywell Intl Inc | $413,000 | +29.5% | 1,940 | 0.0% | 0.21% | +4.0% | |
| FDX | Fedex Corp Com | $338,000 | +3.0% | 1,300 | 0.0% | 0.17% | -17.3% | |
| PFE | Pfizer | $337,000 | +0.3% | 9,150 | 0.0% | 0.17% | -19.7% | |
| MMM | 3M | $236,000 | +9.3% | 1,350 | 0.0% | 0.12% | -12.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-12-30
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JOHNSON &JOHNSON | 38 | Q3 2022 | 0.5% |
| Cabot Corp Com | 37 | Q2 2022 | 16.6% |
| PFIZER INC | 37 | Q2 2022 | 0.3% |
| COTERRA ENERGY INC | 35 | Q4 2021 | 20.7% |
| HONEYWELL INTL INC | 35 | Q4 2021 | 0.3% |
| 3M COMPANY | 34 | Q3 2021 | 0.3% |
| Fedex Corp Com | 34 | Q4 2021 | 0.2% |
| VANGUARD TOTL SM ETF | 31 | Q3 2023 | 66.1% |
| iShares Trust Core | 29 | Q3 2023 | 38.8% |
| GILEAD SCIENCES INC | 23 | Q3 2021 | 10.5% |
View Cabot-Wellington, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-23 |
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-07 |
| 13F-HR | 2023-07-26 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-03-21 |
| 13F-HR | 2023-03-21 |
| 13F-HR | 2023-03-21 |
| 13F-HR | 2023-03-21 |
| 13F-HR | 2023-03-21 |
View Cabot-Wellington, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.